Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration

por Khanani, Arshad M
Publicado 2015

New Therapies of Neovascular AMD beyond Anti-VEGF Injections

por Gahn, Greggory M., Khanani, Arshad M.
Publicado 2018

Cooling Anesthesia for Intravitreal Injections – A Review

por Chandrasekaran, Priya R, Aziz, Aamir A, Khan, Hannah, Khanani, Arshad M
Publicado 2023

Gains in the current understanding of managing neovascular AMD with brolucizumab

por Bodaghi, Bahram, Khanani, Arshad M., Khoramnia, Ramin, Pavesio, Carlos, Nguyen, Quan Dong
Publicado 2023

OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

por Khanani, Arshad M., Eichenbaum, David, Schlottmann, Patricio G., Tuomi, Lisa, Sarraf, David
Publicado 2018

Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab

por Khan, Majid, Aziz, Aamir A., Shafi, Noah A., Abbas, Tayeb, Khanani, Arshad M.
Publicado 2020

Effectiveness of ocriplasmin in real‐world settings: A systematic literature review, meta‐analysis, and comparison with randomized trials

por Khanani, Arshad M., Constantine, Ryan N., Blot, Koenraad H., Lescrauwaet, Benedicte, Szurman, Peter
Publicado 2020

Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020

por Samanta, Anindya, Aziz, Aamir A., Jhingan, Mahima, Singh, Sumit Randhir, Khanani, Arshad, Chhablani, Jay
Publicado 2020

Cooling Anesthesia for Intravitreal Injection: Results of the Prospective Open-Label, Dose-Ranging COOL-1 Trial

por Chao, Daniel L, Rinella, Nicolas T, Khanani, Arshad M, Wykoff, Charles C, Kim, Gun-Ho
Publicado 2021

Macular Telangiectasia Type 2: A Comprehensive Review

por Kedarisetti, Kiran Chandra, Narayanan, Raja, Stewart, Michael W, Reddy Gurram, Nikitha, Khanani, Arshad M
Publicado 2022

Port delivery system with ranibizumab (Susvimo) recall- What does it mean to the retina specialists

por Sharma, Ashish, Khanani, Arshad M., Parachuri, Nikulaa, Kumar, Nilesh, Bandello, Francesco, Kuppermann, Baruch D.
Publicado 2023

Home vision monitoring in patients with maculopathy: current and future options for digital technologies

por Balaskas, Konstantinos, Drawnel, Faye, Khanani, Arshad M., Knox, Paul C., Mavromaras, George, Wang, Yi-Zhong
Publicado 2023

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

por Kiss, Szilárd, Dugel, Pravin U, Khanani, Arshad M, Broder, Michael S, Chang, Eunice, Sun, Gordon H, Turpcu, Adam
Publicado 2018

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better

por Khanani, Arshad M, Gahn, Greggory M, Koci, Micaela M, Dang, Jonathan M, Brown, Sandra M, Hill, Lauren F
Publicado 2019

Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials

por Singer, Michael, Liu, Mimi, Schlottmann, Patricio G, Khanani, Arshad M, Hemphill, Miranda, Hill, Lauren, Tuomi, Lisa, Haskova, Zdenka
Publicado 2020

RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

por Kaiser, Peter K., Wykoff, Charles C., Singh, Rishi P., Khanani, Arshad M., Do, Diana V., Patel, Hersh, Patel, Nikhil
Publicado 2021

Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

por Khan, Hannah, Aziz, Aamir A, Sulahria, Humza, Khan, Huma, Ahmed, Abrahim, Choudhry, Netan, Narayanan, Raja, Danzig, Carl, Khanani, Arshad M
Publicado 2023

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)

por Drenser, Kimberly A, Pieramici, Dante J, Gunn, Joseph M, Rosberger, Daniel F, Kozma, Petra, Fineman, Mitchell S, Duchateau, Luc, Khanani, Arshad M
Publicado 2021

Angiopoietins as Potential Targets in Management of Retinal Disease

por Khanani, Arshad M, Russell, Matthew W, Aziz, Aamir A, Danzig, Carl J, Weng, Christina Y, Eichenbaum, David A, Singh, Rishi P
Publicado 2021

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema

por Dugel, Pravin U., Khanani, Arshad M., Berger, Brian B., Patel, Sunil, Fineman, Mitchell, Jaffe, Glenn J., Kozma-Wiebe, Petra, Heier, Jeffrey
Publicado 2021